Company intelligence / Profile preview
Janssen Biotech
Horsham, Pennsylvania, United States
- Ownership
- Private
- Employees
- ~7000
- Development stage
- Other
01
Overview
Janssen Biotech, as part of Johnson & Johnson Innovative Medicine, markets multiple FDA-approved drugs in immunology, oncology, infectious disease, and neuroscience. The portfolio includes both first-in-class and best-in-class therapies, with a robust late-stage pipeline and more than 11 new molecular entities approved globally since 2011. Pipeline assets range from preclinical to phase 3, with indications spanning cancers, immunological, and infectious diseases.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesPulmonologyDermatologyCardiovascularOncologyNeurology
- Modalities
- Monoclonal antibodySmall moleculeGene therapyVaccineRNA therapyCRISPR-based therapy
- Industry
- Pharma
02
Drug pipeline
52 assets51 more assets in the full pipeline.
Request access →03
Partnerships
Pipeline TherapeuticsArrowhead PharmaceuticalsLocus Biosciences
Beyond the preview
Go deeper on Janssen Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Janssen Biotech.